C. Barbieux

Most-cited papers

1. Manganese superoxide dismutase in breast cancer: from molecular mechanisms of gene regulation to biological and clinical significance.

   P. Becuwe, M. Ennen, R. Klotz, C. Barbieux +1 more

   2014Free Radical Biology & Medicine99 citations Open access

   Semantic Scholar

   Save

2. Secukinumab Therapy for Netherton Syndrome.

   I. Luchsinger, N. Knöpfel, M. Theiler, Mathilde Bonnet Des Claustres +8 more

   2020JAMA dermatology89 citations Open access

   Semantic Scholar

   Save

3. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses.

   C. Barbieux, Mathilde Bonnet Des Claustres, M. Fahrner, E. Petrova +10 more

   2021Journal of Allergy and Clinical Immunology60 citations Open access

   Semantic Scholar

   Save

4. DDB2: a novel regulator of NF-κB and breast tumor invasion.

   M. Ennen, R. Klotz, N. Touche, S. Pinel +11 more

   2013Cancer Research43 citations Open access

   Semantic Scholar

   Save

5. Efficacy of dupilumab for controlling severe atopic dermatitis in a patient with hyper-IgE syndrome

   R. Lévy, V. Béziat, C. Barbieux, A. Puel +3 more

   2020Journal of Clinical Immunology39 citations Open access

   Semantic Scholar

   Save

6. Effects of Bioactive Marine-Derived Liposomes on Two Human Breast Cancer Cell Lines

   J. Li, K. Elkhoury, C. Barbieux, M. Linder +4 more

   2020Marine Drugs22 citations Open access

   Semantic Scholar

   Save

7. Transgenic kallikrein 14 mice display major hair shaft defects associated with desmoglein 3 and 4 degradation, abnormal epidermal differentiation and Il-36 signature.

   O. Gouin, C. Barbieux, F. Leturcq, Mathilde Bonnet Des Claustres +2 more

   2020Journal of Investigative Dermatology17 citations Open access

   Semantic Scholar

   Save

8. DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells.

   C. Barbieux, Jalal Bacharouche, C. Soussen, Sébastien Hupont +7 more

   2016Nanoscale15 citations

   Semantic Scholar

   Save

9. Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways

   E. Petrova, Jesús M. López-Gay, M. Fahrner, F. Leturcq +7 more

   2024Communications Biology13 citations Open access

   Semantic Scholar

   Save

10. Interaction of Iron II Complexes with B-DNA. Insights from Molecular Modeling, Spectroscopy, and Cellular Biology

    Hugo Gattuso, Thibaut Duchanois, V. Besancenot, C. Barbieux +5 more

    2015Frontiers in Chemistry7 citations Open access

    Semantic Scholar

    Save

11. Manganese superoxide dismutase in breast cancer : From molecular mechanisms of gene regulation to biological and clinical signi fi cance

    P. Becuwe, M. Ennen, R. Klotz, C. Barbieux +2 more

    20172 citations

    Semantic Scholar

    Save

12. 884 Treatment of Netherton syndrome patients with Ixekizumab: A case series

    C. Barbieux, M. Claustres, M. Bagot, E. Bourrat +1 more

    20201 citations Open access

    Semantic Scholar

    Save

13. 117 Molecular signatures of skin barrier defect and inflammation in Netherton syndrome uncovered by comparing patients to viable Spink5 knock-out mice

    E. Petrova, J. M. Lopez-Gay Orts, M. Fahrner, F. Leturcq +6 more

    2023Journal of Investigative Dermatology0 citations

    Semantic Scholar

    Save

14. 508 Skin barrier defect and inflammation in Netherton syndrome: Lessons from a comparative study of patients and mouse models

    E. Petrova, J. Orts, M. Fahrner, F. Leturcq +7 more

    2022Journal of Investigative Dermatology0 citations Open access

    Semantic Scholar

    Save

15. 183 Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity

    D. Darbord, G. Hickman, N. Pironon, C. Barbieux +5 more

    2021Journal of Investigative Dermatology0 citations Open access

    Semantic Scholar

    Save

16. 228 IL-36 is a hallmark of Netherton syndrome with type I IFN, Th2 and Th9 responses distinguishing its dual clinical presentation

    C. Barbieux, M. Bonnet-des-Claustres, M. Fahrner, L. Tsoi +6 more

    2021Journal of Investigative Dermatology0 citations Open access

    Semantic Scholar

    Save

17. ESDR228 - IL-36 is a hallmark of Netherton syndrome with type I IFN, Th2 and Th9 responses distinguishing its dual clinical presentation

    C. Barbieux

    20210 citations

    Semantic Scholar

    Save

18. Supplementary Barbieux et al

    C. Barbieux, M. Claustres, M. de la Brassinne, G. Bricteux +3 more

    20200 citations

    Semantic Scholar

    Save

19. 200 Transgenic kallikrein 14 mice display major hair defects associated with desmoglein 3 and 4 degradation and an inflammatory signature

    O. Gouin, C. Barbieux, F. Leturcq, M. Claustres +2 more

    2019Journal of Investigative Dermatology0 citations Open access

    Semantic Scholar

    Save

20. The Damaged DNA Binding 2 protein: a new modulator of TGFβ-1 signaling pathway and membrane nanomechanics in breast cancer cells

    C. Barbieux, G. Francius, R. Klotz, V. Besancenot +6 more

    20150 citations

    Semantic Scholar

    Save

21. The transcriptional regulator DDB2 modulates TGFβ1 signaling and membrane nanomechanics of breast cancer cells

    C. Barbieux, G. Francius, R. Klotz, V. Besancenot +6 more

    20150 citations

    Semantic Scholar

    Save

22. The transcriptional regulator DDB2 modulates TGF beta 1 signaling and cell adhesion in breast cancer cells

    C. Barbieux, G. Francius, R. Klotz, M. Ennen +8 more

    20140 citations

    Semantic Scholar

    Save

23. Molecular and Cellular Pathobiology DDB 2 : A Novel Regulator of NFk B and Breast Tumor Invasion

    M. Ennen, R. Klotz, Nad Ege Touche, S. Pinel +11 more

    20130 citations

    Semantic Scholar

    Save